PubMed Health⌕ Search

Biomedical subjects

Vias Markides

Publications and source records attributed to Vias Markides.

17 recordsLinked to original sources
PubMed2006

Ablation of difficult right-sided accessory pathways aided by mapping of tricuspid annular activation using a Halo catheter : Halo-mapping of right sided accessory pathways.

OBJECTIVE: To demonstrate that the use of a 20-pole catheter (Halotrade mark) positioned around the tricuspid valve annulus (TVA) is helpful in rapidly localising right free wall accessory pathways (AP), enhancing catheter stability during ablation, and leading to increased success in ablating these challenging pathways. PATIENTS AND METHODS: Seven consecutive patients who underwent Halo-mapping of right-sided AP were studied. All but one had previously failed ablation. With a Halo catheter deployed at TVA, the accessory pathway location was rapidly identified using the sites of earliest atrial (A) activation during ventricular (V) pacing or orthodromic tachycardia, or earliest V-activation during sinus rhythm or A-pacing were identified. The stability of the ablation catheter was guided fluoroscopically (with reference to the stationary Halo), and electrically (contact artefact between the ablation catheter and Halo poles). RESULTS: AP locations were identified by the Halo (anterior in one patient, antero-lateral in one, lateral in two, and postero-lateral in three) where similar local VA/AV intervals were recorded at both the ablation catheter and Halo bipoles recording the shortest VA/AV intervals (four of seven patients), contact artefact between the ablation catheter and those Halo bipoles was seen (six of seven patients), or both (three of seven patients). All APs were ablated successfully after a mean RF duration of 5+/-2 min, and 25+/-17 min post Halo deployment without clinical recurrence at 12+/-4 months follow-up. CONCLUSION: A Halo positioned at the TVA can ease the localisation of right-sided AP, facilitate catheter stability during ablation, and guides successful ablation.

Adult↗
PubMed2006

Age-related changes in human left and right atrial conduction.

INTRODUCTION: Advancing age is an independent risk factor for atrial fibrillation (AF), which is considered to be initiated by ectopic triggers and maintained by an arrhythmogenic substrate. It is not known whether substrate changes produce this age-related increase in propensity toward AF. We addressed the hypothesis that advancing age is associated with changes in biatrial electrophysiology even in patients with no history of atrial arrhythmias. METHODS AND RESULTS: Patients with left-sided accessory pathways and requiring routine electrophysiological studies were recruited. Electroanatomic mapping was performed in the left and right atria of 23 patients (age ranging from 17 to 75 years) with structurally normal hearts and no history of AF during sinus rhythm and pacing. Unlike previous studies, a trigonometric method was used to quantify wavefront propagation velocities (WPV) precisely in the direction of propagation. Refractoriness was measured at 2 cycle lengths, at three different atrial sites. Both right (r =-0.77, P < 0.0001) and left (r =-0.79, P < 0.001) atrial WPV demonstrated strongly inverse correlation with age. Furthermore, left and right WPVs were highly correlated (r = 0.66, P < 0.01), with velocities being 6.4 +/- 2.2 cm/sec higher in the right atria (P < 0.01). Refractoriness was significantly correlated with increasing age only at the septum (r = 0.53, P < 0.01). Left atrial wavelength was inversely correlated with increasing age (r =-0.56, P = 0.03). P wave duration was associated with age (r = 0.42, P = 0.04) and left atrial size (r = 0.44, P = 0.04) but not atrial WPV. CONCLUSION: Aging human atria demonstrate progressive decline in WPV and increase in septal refractoriness. These age-related changes in biatrial electrophysiology are likely to be important factors in the age-related increase in AF prevalence.

Adolescent↗
PubMed2005

New mapping technologies: an overview with a clinical perspective.

Conventional catheter mapping techniques continue to form the basis of mapping for all arrhythmias. Constantly evolving "advanced" mapping systems can facilitate arrhythmia mapping by allowing reconstruction of three-dimensional models of cardiac chambers, combining electrical and anatomical information at multiple sites, creating voltage and activation maps and reducing the need for fluoroscopy.

Arrhythmias, Cardiac↗
PubMed2005

Long-term results after ablation of infarct-related ventricular tachycardia.

OBJECTIVES: The purpose of this study was to assess the long-term effects of ablation of infarct-related ventricular tachycardia (VT) and the subsequent requirement for implantable cardioverter-defibrillator (ICD) therapy. BACKGROUND: The long-term consequences after initially successful catheter ablation of infarct-related VT remain unclear. METHODS: Forty patients who presented with infarct-related VT were studied using noncontact mapping to guide ablation. RESULTS: One hundred forty VTs were mapped using the noncontact mapping system, including 36 (25.7%) clinical VTs. An endocardial exit site was determined in 100% of VT circuits, diastolic endocardial activity in 77 VTs (55%), and complete circuits in 24 VTs (17.1%). Eighty-one VTs (57.9%) were targeted for ablation, of which 67 (82.7% of targeted) were successfully ablated, including 27 clinical VTs (75% of clinical). Documented recurrence of an ablated VT occurred in 7.5% of patients over 36.3 +/- 21.0 months of follow-up. Episodes of new or recurrent, nontargeted VT or ventricular fibrillation (VF) occurred in 37.5% and VT recurrence without documentation of cycle length in 5%. In patients with ICDs, mean shock frequency was reduced from 6.8 +/- 7.3 per month in the year prior to ablation to 0.05 +/- 0.12 per month after ablation, over 24.7 +/- 18.9 months of follow-up (P < .0001). CONCLUSIONS: In patients with infarct-related VT, noncontact mapping-guided VT ablation is associated with a high procedural success rate, and VT recurrence necessitating ICD therapy delivery is significantly reduced. However, only 42.5% of patients remain free from VT/VF 3 years after ablation. Catheter ablation for infarct-related VT is indicated as an adjunctive therapy in patients with symptomatic VT but cannot substitute for ICDs and antiarrhythmic drugs.

Aged↗
PubMed2004

Clinical usefulness of cryomapping for ablation of tachycardias involving perinodal tissue.

OBJECTIVES: Radiofrequency (RF) ablation near the AV node carries a significant risk of AV block. We report our initial experience of using cryomapping function to aid the safe cryoablation close to the compact atrioventricular (AV) node. METHODS: Five consecutive patients with para-Hisian accessory pathways (AP) ( n = 2), or focal atrial tachycardia (AT) originating near the AV node ( n = 3) underwent cryoablation using a 7F 4 mm-tipped catheter. At each prospective ablation site, cryo-mapping (-30 degrees C) which causes transient electrical dysfunction was performed, and in the absence of AH interval prolongation, a full cryoablation (<or=-70 degrees C) was applied to the same site. RESULTS: The AT foci, left in 2 patients and right in 1, and the APs were located 1.9 +/- 3.0 mm and 4.5 +/- 8.1 mm from the catheter recording the His deflection in two orthogonal radiographic projections. A His signal (0.18 +/- 0.07 mV) was recorded at the site of successful cryoablation in both patients with AP and 1 with right AT. There was no change in AV nodal function during/after ablation. At each successful cryoablation site, interruption of target pathway/focus function was observed during cryo-mapping after 19.8 +/- 12.4 s. Full cryoablation at sites where cryo-mapping had not caused an effect did not then produce any further electrophysiologic effect. All pathways and foci were ablated successfully without complications, using 3.2 +/- 3.9 cryothermic applications alone in 4 patients, and after a supplementary RF ablation in 1. All patients remained free of arrhythmia at 15 +/- 8 months follow-up. CONCLUSION: Cryomapping may help identify sites for safe and effective ablation of pathways and foci located near the AV node.

Adult↗
PubMed2004

Percutaneous pulmonary vein cryoablation to treat atrial fibrillation.

BACKGROUND: Cryothermic tissue injury, unlike hyperthermic tissue injury, preserves tissue architecture and causes less thrombus formation, and thus may prevent venous stenosis and stroke in ablating pulmonary veins (PVs) to treat patients with atrial fibrillation (AF). We investigate the feasibility, efficacy, safety and clinical outcome of using percutaneous cryoablation to treat such patients. METHODS: Thirty-one patients who had drug refractory paroxysmal (20) or persistent (11) AF underwent 37 PV ablative procedures using a 4 mm- or 6 mm-tipped 7F cryoablation catheter (CryoCath Technologies Inc., Quebec, Canada). Segmental isolation at the veno-atrial junction was guided by a distal circumferential mapping catheter. RESULTS: A total of 47 PV were ablated, of which 35/47 (74%) were electrically isolated and the remaining 12/47 had attenuation of PV electrograms, altered activation sequence, and marked slowing of left atrial-PV conduction. There was no change in PV diameter, either immediately following cryoablation (21 +/- 5 versus 22 +/- 6, p = 0.69), or at 18 +/- 9 months follow-up (22 +/- 5 versus 22 +/- 5 mm, p = 0.23). There was no clinical thromboembolic event. The duration of cryoablation for each treated PV and procedural duration was 65 +/- 39 and 290 +/- 101 min, respectively. Following cryoablation, 5/30 (6%) were free from AF and 12/30 (43%) showed improvement from previously ineffective antiarrhythmic drug therapy. 13/30 (43%) patients were unchanged by cryoablation. CONCLUSIONS: Cryothermic ablation shows great promise in reducing the risks of PV stenosis and thrombo-embolism associated with PV isolative procedures. However, cryoablation of these veins with linear catheters is time consuming, and the clinical outcomes are disappointing. Alternative catheter designs are required to overcome these difficulties.

Analysis of Variance↗
PubMed2004

Percutaneous isolation of multiple pulmonary veins using an expandable circular cryoablation catheter.

Although radiofrequency pulmonary vein (PV) ablation is effective in the treatment of atrial fibrillation (AF), it is associated with small but significant risks of PV stenosis and systemic thromboembolism. The characteristics of cryothermic tissue injury may reduce the likelihood of such complications, but using conventionally tipped cryoablation catheters can be time consuming and may, thus, not permit isolation of all PVs during a single procedure. We describe a case of rapid and effective isolation of all electrically connected PVs in a patient with paroxysmal AF, using a percutaneous self-expanding circular-tipped cryoablation catheter.

Adult↗
PubMed2004

Catheter inversion: a technique to complete isthmus ablation and cure atrial flutter.

Cure of typical atrial flutter (AFL) by catheter ablation to produce bidirectional block across the tricuspid annulus-inferior vena cava isthmus (IS) is highly effective, but failures may occur. We describe a technique that may allow creation of bidirectional block where a conventional strategy has failed. AFL ablation was performed using the conventional approach with a mapping/ablation (ablation) catheter introduced via the right femoral vein (RFV) to create a line of bidirectional block across the IS. If this was not achieved after five passes of the ablation catheter from the tricuspid annulus to the inferior vena cava (IVC) a catheter inversion technique was used. This allowed stable positioning of the ablation catheter at the IVC end of the isthmus. In 11 patients, a mean of 17 (range 3 to 45) radiofrequency (RF) applications was given before the catheter inversion technique was applied. Following catheter inversion a mean of 4 (1 to 14) further RF applications achieved bidirectional isthmus block in every patient. No complications occurred. Catheter inversion provides a simple, safe, and effective means of achieving bidirectional isthmus conduction block in cases where a conventional ablation strategy might have failed.

Aged↗
PubMed2003

Characterization of left atrial activation in the intact human heart.

BACKGROUND: The patterns of activation of the human left atrium (LA), how they relate to atrial myocardial architecture, and their role in arrhythmogenesis remain largely unknown. METHODS AND RESULTS: Left atrial endocardial activation was mapped in 19 patients with a percutaneous noncontact mapping system. Earliest endocardial breakthrough during sinus rhythm (SR) occurred more frequently in the septal (63%, principally posteroseptal) than anterosuperior (37%) LA and varied little with isoproterenol or high right atrial pacing rate. Regardless of site of breakthrough, LA activation was characterized in all patients by propagation around a variably complete line of functional conduction block, descending on the posterior wall from the roof, passing between the ostia of the superior and then inferior pulmonary veins (PVs) before turning septally, passing below the oval fossa, and merging further anteriorly with the septal mitral annulus. Examination of the myocardial architecture in 10 normal adult postmortem hearts revealed an abrupt change in subendocardial fiber orientation along a line following the same course. During episodes of focal initiation of atrial fibrillation (AF), interaction was observed between wavefronts entering the LA from PVs and this functional line of conduction block that resulted in LA macroreentry or formation of daughter wavefronts. CONCLUSIONS: The LA endocardium has complex but characteristic patterns of activation during sinus rhythm, pacing, and AF initiation by PV ectopy that are determined largely by the functional properties of atrial musculature. These findings have important implications for both pacing and ablative strategies for the prevention of initiation of AF.

Adult↗
PubMed2002

Atrial fibrillation: strategies to control, combat, and cure.

Atrial fibrillation is the commonest clinical arrhythmia, is increasing in incidence and prevalence, and is associated with substantial morbidity and mortality. The arrhythmia may be paroxysmal (self-limiting), persistent (amenable to cardioversion), or permanent. Especially in its paroxysmal form, atrial fibrillation may be initiated by rapidly firing foci, generally located in the proximal pulmonary veins. Sustained atrial fibrillation is maintained by an atrial tissue substrate capable of accommodating many meandering wavelets. With continuing arrhythmia, the electrophysiological properties of the atria change and further facilitate continuing fibrillation. Treatment is aimed at prevention of thromboembolic complications, restoration and maintenance of sinus rhythm, and control of ventricular rate during atrial fibrillation. With greater understanding of the arrhythmia mechanisms, it is becoming possible to offer targeted curative treatments to more and more patients.

Aged↗
PubMed2002

Mechanisms underlying the development of atrial arrhythmias in heart failure.

There is an important association between heart failure and the development of atrial arrhythmias. Although most often associated with atrial fibrillation, there is some evidence to suggest an association between heart failure and other atrial arrhythmias and, in particular, atrial flutter and atrial tachycardia. The mechanisms by which these common atrial arrhythmias may arise in patients with heart failure are discussed.

Aged↗